ASCO, SGO Clarify Chemo Role in Ovarian Cancer (CME/CE)
(MedPage Today) -- High clinical risk, low surgical success favor neoadjuvant therapy
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Ovarian Cancer | Ovaries